Tengion has named Diane Jorkasky, M.D. to its board of directors. Jorkasky recently joined Endo Pharmaceuticals as senior vice president, clinical development and chief medical officer. She was previously chief development and medical officer at Aileron Therapeutics.

"We are pleased to welcome Diane to the Board and look forward to tapping into her extensive clinical development experience as we move our product candidates forward," said David Scheer, chairman of the Tengion board of directors.

Tengion also announced today that Brenda Gavin, D.V.M., managing partner at Quaker BioVentures, is stepping down from the Tengion board of directors after five years of service.